RETRACTED: Zhou et al. Pyrvinium Treatment Confers Hepatic Metabolic Benefits via β-Catenin Downregulation and AMPK Activation. Pharmaceutics 2021, 13, 330

Detalles Bibliográficos
Autores principales: Zhou, Shiwei, Obianom, Obinna N., Huang, Jiangsheng, Guo, Dong, Yang, Hong, Li, Qing, Shu, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Retraction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10301172/
https://www.ncbi.nlm.nih.gov/pubmed/37376227
http://dx.doi.org/10.3390/pharmaceutics15061623

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10301172/
https://www.ncbi.nlm.nih.gov/pubmed/37376227
http://dx.doi.org/10.3390/pharmaceutics15061623

Ejemplares similares